{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:18:13Z","timestamp":1787980693159,"version":"build-2784847793"},"reference-count":44,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j144","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:09:12Z","timestamp":1768428552000},"page":"351-361","source":"Crossref","is-referenced-by-count":0,"title":["Role of MALAT1 in the Progression of ACLF via the miR-141-3p\/TGFB2 Axis and Its Association with Patient Prognosis"],"prefix":"10.1620","volume":"269","author":[{"given":"Yan","family":"Qiao","sequence":"first","affiliation":[{"name":"Department of General Surgery I, Hongqi Hospital Affiliated to Mudanjiang Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgeng Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery I, Hongqi Hospital Affiliated to Mudanjiang Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Practice, Chinese and Western Medicine Hospital of Panzhihua"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xincheng Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Abbas, N., Rajoriya, N., Elsharkawy, A.M.&Chauhan, A. (2022) Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived? Expert. Rev. Gastroenterol. Hepatol.<\/i>, 16, 639-652. https:\/\/doi.org\/10.1080\/17474124.2022.2097070","DOI":"10.1080\/17474124.2022.2097070"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Abbas, Z.&Shazi, L. (2015) Pattern and profile of chronic liver disease in acute on chronic liver failure. Hepatol. Int.<\/i>, 9, 366-372. https:\/\/doi.org\/10.1007\/s12072-015-9627-z","DOI":"10.1007\/s12072-015-9627-z"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Aday, A.&O'Leary, J.G. (2020) Acute on Chronic Liver Failure: Definition and Implications. Clin. Liver. Dis.<\/i>, 24, 521-534. https:\/\/doi.org\/10.1016\/j.cld.2020.04.004","DOI":"10.1016\/j.cld.2020.04.004"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Adugna, A., Muche, Y., Melkamu, A., Jemal, M., Belew, H.&Amare, G.A. (2024) Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy. Heliyon<\/i>, 10, e34288. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34288","DOI":"10.1016\/j.heliyon.2024.e34288"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Agarwal, B., Canizares, R.B., Saliba, F., Ballester, M.P., Tomescu, D.R., Martin, D., Stadlbauer, V., Wright, G., Sheikh, M., Morgan, C., Alzola, C., Lavin, P., Green, D., Kumar, R., Sacleux, S.C., et al. (2023) Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure. J. Hepatol.<\/i>, 79, 79-92. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.013","DOI":"10.1016\/j.jhep.2023.03.013"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Alam, A., Chun Suen, K.&Ma, D. (2017) Acute-on-chronic liver failure: recent update. J. Biomed. Res.<\/i>, 31, 283-300. https:\/\/doi.org\/10.7555\/JBR.30.20160060","DOI":"10.7555\/JBR.30.20160060"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Allen, A.M.&Kim, W.R. (2016) Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure. Semin. Liver Dis.<\/i>, 36, 123-126. https:\/\/doi.org\/10.1055\/s-0036-1583201","DOI":"10.1055\/s-0036-1583201"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Bai, J., Xu, M., Peng, F., Gong, J., Song, X.&Li, Y. (2023) A nomogram based on psoas muscle index predicting long-term cirrhosis incidence in non-cirrhotic patients with HBV-related acute-on-chronic liver failure. Sci. Rep.<\/i>, 13, 21265. https:\/\/doi.org\/10.1038\/s41598-023-47463-4","DOI":"10.1038\/s41598-023-47463-4"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Bernal, W., Jalan, R., Quaglia, A., Simpson, K., Wendon, J.&Burroughs, A. (2015) Acute-on-chronic liver failure. Lancet<\/i>, 386, 1576-1587. https:\/\/doi.org\/10.1016\/S0140-6736(15)00309-8","DOI":"10.1016\/S0140-6736(15)00309-8"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Bu, F.T., Wang, A., Zhu, Y., You, H.M., Zhang, Y.F., Meng, X.M., Huang, C.&Li, J. (2020) LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases. Liver Int.<\/i>, 40, 2612-2626. https:\/\/doi.org\/10.1111\/liv.14629","DOI":"10.1111\/liv.14629"},{"key":"11","unstructured":"Chaleshi, V., Asadzadeh Aghdaei, H., Nourian, M., Iravani, S., Jalaeikhoo, H., Rajaeinejad, M., Khoshdel, A.R.&Naghoosi, H. (2021) Association of MALAT1 expression in gastric carcinoma and the significance of its clinicopathologic features in an Iranian patient. Gastroenterol. Hepatol. Bed. Bench.<\/i>, 14, 108-114."},{"key":"12","doi-asserted-by":"publisher","unstructured":"Chen, H., Zeng, L., Zheng, W., Li, X.&Lin, B. (2020) Increased Expression of microRNA-141-3p Improves Necrotizing Enterocolitis of Neonates Through Targeting MNX1. Front. Pediatr.<\/i>, 8, 385. https:\/\/doi.org\/10.3389\/fped.2020.00385","DOI":"10.3389\/fped.2020.00385"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Chen, J., Ao, L.&Yang, J. (2019) Long non-coding RNAs in diseases related to inflammation and immunity. Ann. Transl. Med.<\/i>, 7, 494. https:\/\/doi.org\/10.21037\/atm.2019.08.37","DOI":"10.21037\/atm.2019.08.37"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Chen, L., Kang, X., Meng, X., Huang, L., Du, Y., Zeng, Y.&Liao, C. (2023) MALAT1-mediated EZH2 Recruitment to the GFER Promoter Region Curbs Normal Hepatocyte Proliferation in Acute Liver Injury. J. Clin. Transl. Hepatol.<\/i>, 11, 97-109. https:\/\/doi.org\/10.14218\/JCTH.2021.00391","DOI":"10.14218\/JCTH.2021.00391"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Chen, M., Peng, J., Zhu, G., Qian, C., Xiao, Z., Song, X., Yu, H., Huang, R., Wang, W., Zheng, H.&Yu, Y. (2024) Long noncoding RNA MALAT1 as a ceRNA drives mouse fibroblast activation via the miR-335-3p\/P2ry2 axis. PLoS One<\/i>, 19, e0308723. https:\/\/doi.org\/10.1371\/journal.pone.0308723","DOI":"10.1371\/journal.pone.0308723"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Chouhan, M.D., Taylor, S.A., Bainbridge, A., Walker-Samuel, S., Davies, N., Halligan, S., Lythgoe, M.F.&Mookerjee, R.P. (2021) Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI. Eur. Radiol.<\/i>, 31, 2518-2528. https:\/\/doi.org\/10.1007\/s00330-020-07259-w","DOI":"10.1007\/s00330-020-07259-w"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Cisilotto, J., do Amaral, A.E., Rosolen, D., Rode, M.P., Silva, A.H., Winter, E., da Silva, T.E., Fischer, J., Matiollo, C., Rateke, E.C.M., Narciso-Schiavon, J.L., Schiavon, L.L.&Creczynski-Pasa, T.B. (2020) MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction. Sci. Rep.<\/i>, 10, 100. https:\/\/doi.org\/10.1038\/s41598-019-56630-5","DOI":"10.1038\/s41598-019-56630-5"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Eringyte, I., Zamarbide Losada, J.N., Powell, S.M., Bevan, C.L.&Fletcher, C.E. (2020) Coordinated AR and microRNA regulation in prostate cancer. Asian J. Urol.<\/i>, 7, 233-250. https:\/\/doi.org\/10.1016\/j.ajur.2020.06.003","DOI":"10.1016\/j.ajur.2020.06.003"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Fang, X., Wang, H., Zhuo, Z., Tian, P., Chen, Z., Wang, Y.&Cheng, X. (2021) miR-141-3p inhibits the activation of astrocytes and the release of inflammatory cytokines in bacterial meningitis through down-regulating HMGB1. Brain Res.<\/i>, 1770, 147611. https:\/\/doi.org\/10.1016\/j.brainres.2021.147611","DOI":"10.1016\/j.brainres.2021.147611"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Genena, S., Fadhil, M.M., Mansour, M.M., Attwa, A.H.M.&Khalil, M. (2023) Expression pattern of long non-coding RNAs MALAT1 and MEG3 in COVID-19 patients. J. Gene. Med.<\/i>, 25, e3532. https:\/\/doi.org\/10.1002\/jgm.3532","DOI":"10.1002\/jgm.3532"},{"key":"21","unstructured":"Huang, X.&Zhao, M. (2019) High expression of long non-coding RNA MALAT1 correlates with raised acute respiratory distress syndrome risk, disease severity, and increased mortality in sepstic patients. Int. J. Clin. Exp. Pathol.<\/i>, 12, 1877-1887."},{"key":"22","doi-asserted-by":"publisher","unstructured":"Kinnman, N., Andersson, U.&Hultcrantz, R. (2000) In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C. Scand. J. Gastroenterol.<\/i>, 35, 1294-1300. https:\/\/doi.org\/10.1080\/003655200453656","DOI":"10.1080\/003655200453656"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Li, R., Jin, J., Liu, E.&Zhang, J. (2022) A novel circulating biomarker lnc-MALAT1 for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events. J. Clin. Lab. Anal.<\/i>, 36, e24771. https:\/\/doi.org\/10.1002\/jcla.24771","DOI":"10.1002\/jcla.24771"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Liao, X., Chen, J., Luo, D., Luo, B., Huang, W.&Xie, W. (2022) Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation. Pathol. Oncol. Res.<\/i>, 28, 1610808. https:\/\/doi.org\/10.3389\/pore.2022.1610808","DOI":"10.3389\/pore.2022.1610808"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Liu, W., Geng, F.&Yu, L. (2020) Long non-coding RNA MALAT1\/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients. J. Clin. Lab. Anal.<\/i>, 34, e23222. https:\/\/doi.org\/10.1002\/jcla.23222","DOI":"10.1002\/jcla.23222"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Luo, X., Chen, K., Zhang, J., Yao, Z., Guo, C., Qu, Y., Lu, L.&Mao, Y. (2025a) Ghrelin alleviates liver fibrosis by triggering HSCs ferroptosis via regulating injured hepatocyte-derived exosomal LncMALAT1\/GPX4 pathway. FASEB J.<\/i>, 39, e70297. https:\/\/doi.org\/10.1096\/fj.202401985RR","DOI":"10.1096\/fj.202401985RR"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Luo, Y., Ren, Q., He, J.&Wu, M. (2025b) miR-126-3p Serves as a Biomarker for Hepatitis B Virus-Associated Chronic Acute Liver Failure and Regulates Inflammation by Regulating ERRFI1. J. Biochem. Mol. Toxicol.<\/i>, 39, e70252. https:\/\/doi.org\/10.1002\/jbt.70252","DOI":"10.1002\/jbt.70252"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Ma, L., Shao, H., Chen, H.&Deng, Q. (2021) The Mechanism of miR-141 Regulating the Proliferation and Metastasis of Liver Cancer Cells by Targeting STAT4. J. Oncol.<\/i>, 2021, 5425491. https:\/\/doi.org\/10.1155\/2021\/5425491","DOI":"10.1155\/2021\/5425491"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Ma, L., Wei, J., Zeng, Y., Liu, J., Xiao, E., Kang, Y.&Kang, Y. (2022) Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p\/PTEN\/AKT pathway in human liver fibrosis. Drug Deliv.<\/i>, 29, 440-453. https:\/\/doi.org\/10.1080\/10717544.2022.2030428","DOI":"10.1080\/10717544.2022.2030428"},{"key":"30","doi-asserted-by":"crossref","unstructured":"McCown, P.J., Wang, M.C., Jaeger, L.&Brown, J.A. (2019) Secondary Structural Model of Human MALAT1 Reveals Multiple Structure-Function Relationships. Int. J. Mol. Sci.<\/i>, 20, 5610. https:\/\/doi.org\/10.3390\/ijms20225610","DOI":"10.3390\/ijms20225610"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Oketani, M., Uto, H., Ido, A.&Tsubouchi, H. (2014) Management of hepatitis B virus-related acute liver failure. Clin. J. Gastroenterol.<\/i>, 7, 19-26. https:\/\/doi.org\/10.1007\/s12328-013-0447-1","DOI":"10.1007\/s12328-013-0447-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Piipponen, M., Li, D.&Landen, N.X. (2020) The Immune Functions of Keratinocytes in Skin Wound Healing. Int. J. Mol. Sci.<\/i>, 21, 8790. https:\/\/doi.org\/10.3390\/ijms21228790","DOI":"10.3390\/ijms21228790"},{"key":"33","doi-asserted-by":"publisher","unstructured":"Sarin, S.K.&Choudhury, A. (2016) Acute-on-chronic liver failure: terminology, mechanisms and management. Nat. Rev. Gastroenterol. Hepatol.<\/i>, 13, 131-149. https:\/\/doi.org\/10.1038\/nrgastro.2015.219","DOI":"10.1038\/nrgastro.2015.219"},{"key":"34","doi-asserted-by":"publisher","unstructured":"Sarin, S.K., Choudhury, A., Sharma, M.K., Maiwall, R., Al Mahtab, M., Rahman, S., Saigal, S., Saraf, N., Soin, A.S., Devarbhavi, H., Kim, D.J., Dhiman, R.K., Duseja, A., Taneja, S., Eapen, C.E., et al. (2019) Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol. Int.<\/i>, 13, 353-390. https:\/\/doi.org\/10.1007\/s12072-019-09946-3","DOI":"10.1007\/s12072-019-09946-3"},{"key":"35","doi-asserted-by":"publisher","unstructured":"Sefried, S., Haring, H.U., Weigert, C.&Eckstein, S.S. (2018) Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression. Open Biol.<\/i>, 8, 180147. https:\/\/doi.org\/10.1098\/rsob.180147","DOI":"10.1098\/rsob.180147"},{"key":"36","doi-asserted-by":"publisher","unstructured":"Sun, T., Huang, Z., Liang, W.C., Yin, J., Lin, W.Y., Wu, J., Vernes, J.M., Lutman, J., Caplazi, P., Jeet, S., Wong, T., Wong, M., DePianto, D.J., Morshead, K.B., Sun, K.H., et al. (2021) TGFbeta2 and TGFbeta3 isoforms drive fibrotic disease pathogenesis. Sci. Transl. Med.<\/i>, 13, eabe0407. https:\/\/doi.org\/10.1126\/scitranslmed.abe0407","DOI":"10.1126\/scitranslmed.abe0407"},{"key":"37","doi-asserted-by":"publisher","unstructured":"Wang, L., Qi, Y., Wang, Y., Tang, H., Li, Z., Wang, Y., Tang, S.&Zhu, H. (2019) LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX. Oxid. Med. Cell. Longev.<\/i>, 2019, 8245810. https:\/\/doi.org\/10.1155\/2019\/8245810","DOI":"10.1155\/2019\/8245810"},{"key":"38","doi-asserted-by":"publisher","unstructured":"Wang, T., Li, Q., Xu, R., Zhao, Z., Sun, Q., Xu, X.&Li, R. (2024) Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy. Front. Pharmacol.<\/i>, 15, 1437071. https:\/\/doi.org\/10.3389\/fphar.2024.1437071","DOI":"10.3389\/fphar.2024.1437071"},{"key":"39","doi-asserted-by":"publisher","unstructured":"Wang, X., Jing, R., Yang, T., Shao, R., Yang, F., Shi, Y., Yang, X., An, D.&Liang, Y. (2025) Research progress on non-coding RNA regulatory networks and targeted therapy in diabetic nephropathy. Front. Endocrinol.<\/i> (Lausanne<\/i>), 16, 1625307. https:\/\/doi.org\/10.3389\/fendo.2025.1625307","DOI":"10.3389\/fendo.2025.1625307"},{"key":"40","doi-asserted-by":"publisher","unstructured":"Xu, L., Hu, G., Xing, P., Zhou, M.&Wang, D. (2020) Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1\/miR-370-3p\/HMGB1 axis. Life Sci.<\/i>, 262, 118505. https:\/\/doi.org\/10.1016\/j.lfs.2020.118505","DOI":"10.1016\/j.lfs.2020.118505"},{"key":"41","doi-asserted-by":"publisher","unstructured":"Xu, Y., Liu, H., Xiong, W., Peng, Y., Li, X., Long, X., Jin, J., Liang, J., Weng, R., Liu, J., Zhang, L.&Liu, Y. (2023) A novel mechanism regulating pyroptosis-induced fibrosis in endometriosis via lnc-MALAT1\/miR-141-3p\/NLRP3 pathwaydagger. Biol. Reprod.<\/i>, 109, 156-171. https:\/\/doi.org\/10.1093\/biolre\/ioad057","DOI":"10.1093\/biolre\/ioad057"},{"key":"42","doi-asserted-by":"publisher","unstructured":"You, L., Zheng, Y., Yang, J., Hou, Q., Wang, L., Zhang, Y., Zhao, C.&Xie, R. (2022) LncRNA MDRL Mitigates Atherosclerosis through miR-361\/SQSTM1\/NLRP3 Signaling. Mediators Inflamm.<\/i>, 2022, 5463505. https:\/\/doi.org\/10.1155\/2022\/5463505","DOI":"10.1155\/2022\/5463505"},{"key":"43","doi-asserted-by":"publisher","unstructured":"You, S., Rong, Y., Zhu, B., Zhang, A., Zang, H., Liu, H., Li, D., Wan, Z.&Xin, S. (2013) Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol. Int.<\/i>, 7, 714-720. https:\/\/doi.org\/10.1007\/s12072-013-9424-5","DOI":"10.1007\/s12072-013-9424-5"},{"key":"44","doi-asserted-by":"publisher","unstructured":"Zhou, J., Li, Y., Liu, X., Long, Y.&Chen, J. (2018) LncRNA-Regulated Autophagy and its Potential Role in Drug-Induced Liver Injury. Ann. Hepatol.<\/i>, 17, 355-363. https:\/\/doi.org\/10.5604\/01.3001.0011.7381","DOI":"10.5604\/01.3001.0011.7381"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/3\/269_2025.J144\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:24:38Z","timestamp":1787977478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/3\/269_2025.J144\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j144","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J144"}}